This inventor holds 1 USPTO granted patent and 4 published patent applications and 5 EPO patents. Top assignee: Roche Diabetes Care, Inc.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Ildiko Amann-Zalan: Innovator in Blood Glucose Measurement Technology
Introduction
Ildiko Amann-Zalan is a notable inventor based in Weinheim, Germany. She has made significant contributions to the field of diabetes care, particularly in the area of blood glucose measurement technology. Her innovative approach has led to the development of a unique method for improving the accuracy and efficiency of blood glucose monitoring.
Latest Patents
Ildiko Amann-Zalan holds 1 patent for her invention titled "Automatic user-specific spot BG measuring routine based on user continuous BG measurements." This patent describes a method and data processing device designed to automatically generate a user-specific measuring data recording routine for discontinuous blood glucose measurement. The process involves providing data that indicates an expected continuous course of blood glucose values, generating user-specific measuring routine data, and transmitting this data through a data output interface.
Career Highlights
Throughout her career, Ildiko has worked with prominent companies in the healthcare sector. She has been associated with Roche Diabetes Care, Inc. and F. Hoffmann-La Roche AG, where she has contributed her expertise in diabetes management and technology development. Her work has been instrumental in advancing the tools available for blood glucose monitoring.
Collaborations
Ildiko has collaborated with various professionals in her field, including her coworker Bernhard Trauth. Their joint efforts have focused on enhancing the effectiveness of diabetes care solutions.
Conclusion
Ildiko Amann-Zalan's innovative contributions to blood glucose measurement technology highlight her commitment to improving diabetes management. Her work continues to influence the development of user-friendly and effective monitoring solutions for individuals with diabetes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
